ÂÜÀòÂÒÂ×

George Fazio is Chief Executive Officer and President at Corvia Medical, a U.S. venture-backed company that developed a novel interventional treatment for heart failure.

He has over 30 years of global experience in the cardiovascular medtech industry. As a manager at St. Jude Medical for nearly 20 years, he successfully led several operating divisions in senior leadership and commercial roles in the cardiovascular business across North America and Europe.

In addition to chairing Xeltis Board of Directors. George is currently serving on the Board of BioVentrix Inc. He holds a B.S. from the State University of New York at Albany and an MBA from the Fordham University Graduate School of Business.